Alkermes, Inc.
Clinical trials sponsored by Alkermes, Inc., explained in plain language.
-
New pill aims to fight narcolepsy sleepiness
Disease control Not yet recruitingThis study is testing whether a new tablet called ALKS 2680 can help reduce excessive daytime sleepiness and other symptoms in adults with narcolepsy type 2. About 176 participants will take either the real medication or a placebo (sugar pill) for 12 weeks to see which works bett…
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC
-
New pill aims to tame Narcolepsy's sudden sleep attacks
Disease control Not yet recruitingThis study is testing whether a new tablet called ALKS 2680 can help adults with narcolepsy type 1 stay awake during the day and reduce sudden muscle weakness (cataplexy). About 150 participants will take either the study drug or a placebo (inactive pill) for 12 weeks to see whic…
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC